HeimBAX • NYSE
add
Baxter International Inc
32,87 $
Eftir lokun(0,97%)+0,32
33,19 $
Lokað: 26. nóv., 19:53:10 GMT-5 · USD · NYSE · Lagalegir fyrirvarar
Við síðustu lokun
33,42 $
Dagbil
32,60 $ - 33,60 $
Árabil
31,60 $ - 44,01 $
Markaðsvirði
16,66 ma. USD
Meðalmagn
3,90 m.
V/H-hlutf.
153,63
A/V-hlutfall
2,07%
Aðalkauphöll
NYSE
Viðskiptafréttir
Investor's Business Daily
fyrir 1 klukkustund
Futures: Titans Offset Tariffs; Big Earnings Movers Late
0,28%
0,57%
0,17%
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (USD) | sep. 2024info | Breyting á/á |
|---|---|---|
Tekjur | 2,70 ma. | 3,85% |
Rekstrarkostnaður | 848,00 m. | 6,00% |
Nettótekjur | 140,00 m. | -94,42% |
Hagnaðarhlutfall | 5,19 | -94,62% |
Hagnaður á hvern hlut | 0,80 | 17,65% |
EBITDA | 353,00 m. | -2,22% |
Virkt skatthlutfall | 11,59% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (USD) | sep. 2024info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 1,42 ma. | -75,47% |
Heildareignir | 26,68 ma. | -12,98% |
Heildarskuldir | 18,73 ma. | -16,70% |
Eigið fé alls | 7,94 ma. | — |
Útistandandi hlutabréf | 510,59 m. | — |
Eiginfjárgengi | 2,17 | — |
Arðsemi eigna | 2,11% | — |
Ávöxtun eigin fjár | 2,65% | — |
Peningaflæði
Breyting á handbæru fé
| (USD) | sep. 2024info | Breyting á/á |
|---|---|---|
Nettótekjur | 140,00 m. | -94,42% |
Handbært fé frá rekstri | — | — |
Reiðufé frá fjárfestingum | — | — |
Reiðufé frá fjármögnun | — | — |
Breyting á handbæru fé | — | — |
Frjálst peningaflæði | — | — |
Um
Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois.
The company primarily focuses on products to treat kidney disease, and other chronic and acute medical conditions. The company had 2017 sales of $10.6 billion, across two businesses: BioScience and Medical Products. Baxter's BioScience business produces recombinant and blood plasma proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies and other chronic and acute blood-related conditions; products for regenerative medicine, and vaccines. Baxter's Medical Products business produces intravenous products and other products used in the delivery of fluids and drugs to patients; inhalational anaesthetics; contract manufacturing services; and products to treat end-stage kidney disease, or irreversible kidney failure, including products for peritoneal dialysis and hemodialysis. Wikipedia
Framkvæmdastjóri
Stofnsett
1931
Höfuðstöðvar
Vefsvæði
Starfsfólk
60.000
